Ceribell (CBLL) Gross Margin (2023 - 2026)
Ceribell posted quarterly Gross Margin of 87.27% for Q1 2026, down 61.0% year-on-year from 223.78% in Q1 2025, and little changed on a QoQ basis from 87.33% in Q4 2025.
Ceribell (CBLL) has 4 years of Gross Margin data on file, last reported at 87.27% in Q1 2026.
- For the quarter ending Q1 2026, Gross Margin fell 61.0% year-over-year to 87.27%; the trailing twelve-month figure through Mar 2026 stood at 87.72% (up 47.0% YoY), and the FY2025 full-year result was 87.89%, up 117.0% from the prior year.
- Gross Margin for Q1 2026 stood at 87.27%, roughly flat from 87.33% in the prior quarter.
- Across five years, Gross Margin topped out at 88.28% in Q3 2025 and bottomed at 83.77% in Q3 2023.
- The 4-year median for Gross Margin is 87.3% (2024), against an average of 86.71%.
- The widest annual swing landed in 2024, when Gross Margin surged 353 bps; it then sank 61 bps in 2026.
- A 4-year view of Gross Margin shows it stood at 84.65% in 2023, then gained by 3 bps to 87.61% in 2024, then declined by 0 bps to 87.33% in 2025, then fell by 0 bps to 87.27% in 2026.
- The last three Gross Margin figures came in at 87.27% (Q1 2026), 87.33% (Q4 2025), and 88.28% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 63.83% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 78.01% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 45.22% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 62.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 38.53% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 43.89% |
| 10 | Ceribell | 666.26 Mn | 525.07 Mn | 23.12 Mn | 87.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 87.27% |
| Dec 31, 2025 | 87.33% |
| Sep 30, 2025 | 88.28% |
| Jun 30, 2025 | 88.13% |
| Mar 31, 2025 | 87.88% |
| Dec 31, 2024 | 87.61% |
| Sep 30, 2024 | 87.30% |
| Jun 30, 2024 | 85.92% |
| Mar 31, 2024 | 85.71% |
| Dec 31, 2023 | 84.65% |
| Sep 30, 2023 | 83.77% |